Abbott Laboratories
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 weeks.
- Recent price momentum is -7.1% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 0.8% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Anonymous reader poll. Unscientific, not investment advice.
Performance
Key statistics
Price & volume
- Prev close
- 104.06
- Open
- 105.38
- Day range
- 103.10 - 105.62
- Avg price
- 104.19
- Volume
- 1.94M
- Turnover
- 202.50M
- Turnover ratei
- 0.11%
- Volume ratioi
- 1.02
- Amplitudei
- 2.42%
- 52-week rangei
- 80.89 - 128.82
Valuation
- P/Ei
- 27.86
- P/E (TTM)i
- 33.55
- P/Bi
- 3.51
- EPSi
- 3.72
- Book value / shi
- 29.54
- Net profit
- 6.44B
- Net assets
- 51.11B
Share structure
- Market cap
- 179.36B
- Float capi
- 178.27B
- Shares out
- 1.73B
- Float sharesi
- 1.72B
Dividend & listing
- Div yield (TTM)i
- 2.35%
- Dividend (TTM)
- 2.44
- Listing date
- 1970-01-01
19.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-97.58M net over the window
Short interest
- Shares short
- 13.63M
- % of floati
- 0.79%
- Days to coveri
- 1.46
- As of
- 2026-09-30
Frequently asked questions
What is the current stock price of Abbott Laboratories (ABT)?
Abbott Laboratories last traded at 103.66. The quote on this page refreshes every few seconds while US markets are open.
What is Abbott Laboratories's market cap?
About 179.36B.
What is the P/E ratio of Abbott Laboratories?
The trailing twelve-month P/E is 33.55, above its own 5-year average of 27.87 — toward the top of its historical range (76.33% percentile). See the Valuation tab for the full history.
Does Abbott Laboratories pay a dividend?
Yes. The trailing dividend yield is 2.35%. The 2025 payout was up 7.3% from 2024. See the Dividends tab for the full payment history.
Is Abbott Laboratories a buy according to analysts?
The consensus of 14 analysts is a Buy rating, with an average 12-month price target of 125.50, which implies 21.1% upside from the current price. This is not investment advice.
What is Abbott Laboratories's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Abbott Laboratories a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-20 10:50:03 · For reference only, not investment advice and not tailored to your situation.
Abbott Laboratories discussion 0 comments